For further analyses of the association between GALNT2 expression and other clinicopathologic and biologic factors, NB tumors were assigned to negative GALNT2 expression (“0” in immunoreactivity) and positive GALNT2 expression (“1+”, “2+”, or “3+” in immunoreactivity). This evidence concerns the gene GALNT2 and neuroblastoma.